Loading ......
Betacellulin is an epidermal growth factor family ligand synthesized predominantly as a membrane-tethered precursor and released through proteolytic shedding into paracrine and circulating compartments. First characterized within pancreatic islet biology, the factor stimulates proliferation of beta cells while also engaging epidermal growth factor receptor signaling across epithelial and mesenchymal populations, connecting it to wound repair, vascular remodeling, and metabolic regulation. Aberrant betacellulin abundance has been linked to disturbed glucose homeostasis, dysregulated epithelial proliferation, and neoplastic progression, establishing the ligand as a biomarker of genuine cross-disciplinary interest. Reliable quantitative measurement in serum, plasma, cell culture supernatants, and tissue extracts is therefore foundational to research programs probing metabolic, regenerative, and oncological dimensions of this signaling axis.
Figure 1. Human BTC(Betacellulin) ELISA Kit: Quantitative Profiling of an EGF Family Growth Factor in Pancreatic Biology, Tissue Regeneration and Metabolic Research.
Quantitative interrogation of betacellulin biology confronts investigators with a ligand that exists in multiple molecular states, each carrying distinct biological meaning. The membrane-anchored precursor participates in juxtacrine signaling, whereas the shed soluble ligand travels through biofluids to engage distant receptor populations. Proteolytic release varies with inflammatory stimuli, metabolic state, and tissue injury, so snapshot measurements must be interpreted against sampling context. Matrix effects in serum and plasma further complicate sensitive detection near physiological abundance. A dependable measurement strategy therefore combines a validated sandwich immunoassay for routine quantification with development-grade antibody reagents and recombinant calibrator material, allowing laboratories to extend detection capability, verify specificity, and harmonize results across specimen types and research phases.
| Molecular / Biological Parameters | Descriptions |
| Betacellulin Ligand | Epidermal growth factor family member produced as a membrane-tethered precursor and released by proteolytic shedding; engages the epidermal growth factor receptor and related ErbB receptors to evoke mitogenic and differentiative responses. |
| EGFR/ErbB Signaling Engagement | Downstream receptor phosphorylation cascade activated upon ligand binding; mediates proliferation, migration, and survival signals across pancreatic, epithelial, and vascular cell populations. |
| Circulating Betacellulin in Biofluids | Shed soluble ligand measurable in serum, plasma, and culture supernatants; abundance reflects systemic and local sheddase activity and serves as the principal quantitative readout for metabolic and oncological studies. |
Within pancreatic islets, betacellulin promotes expansion and functional maintenance of insulin-producing beta cells, prompting sustained interest in its contribution to diabetes pathogenesis and regenerative strategies. Shedding of the membrane precursor responds to metabolic cues and inflammatory mediators, linking local islet biology to measurable circulating ligand. Parallel actions on epithelial tissues accelerate wound closure and mucosal repair, while vascular effects support angiogenic remodeling during tissue regeneration. Beyond regenerative physiology, betacellulin signaling participates in disease progression. Sustained receptor activation can drive excessive epithelial proliferation and contributes to progression in several malignancies, where autocrine ligand loops reinforce tumor growth and therapeutic resistance. Metabolic disturbance likewise reshapes circulating ligand abundance, positioning betacellulin as an accessible biomarker bridging endocrine, regenerative, and oncological research domains. Deploying the Human BTC(Betacellulin) ELISA Kit together with development-grade antibody reagents and recombinant ligand standards enables laboratories to quantify the ligand across specimen matrices, verify assay specificity, and extend measurement into custom formats, constructing a coherent analytical foundation for pancreatic, metabolic, and tumor biology investigations.
| Products | Core Advantages | Primary Applicable Scenarios |
| Human BTC(Betacellulin) ELISA Kit | Validated sandwich immunoassay for human betacellulin quantification in serum, plasma, and culture supernatants; streamlined plate workflow; reproducible performance across routine laboratory batches | Circulating ligand quantification in metabolic research; pancreatic biology investigation; biomarker assessment across clinical specimen panels |
| Human Betacellulin ELISA Development Kit | Component-based format supplying matched capture and detection reagents for custom assay assembly; adaptable to bespoke plate designs and matrix combinations; economical for extended research campaigns | Development of in-house betacellulin assays; matrix-optimized method refinement; scale-out across multi-site research programs |
| Betacellulin Human ELISA Kit | Alternative sandwich format for human specimen quantification; independent capture-detection pairing supporting orthogonal confirmation; consistent analytical behavior | Cross-platform result verification; longitudinal specimen measurement; complementary readout in ligand dynamics studies |
| Rabbit anti-Human Betacellulin polyclonal antibody | Polyclonal reagent with broad epitope coverage across the human ligand; suited to immunoassay development, immunodetection, and specificity exploration; consistent lot quality | Assay capture or detection reagent sourcing; tissue expression localization; ligand characterization in discovery research |
| Recombinant Human Betacellulin | Purified recombinant ligand serving as calibrator and control material; authentic folded conformation for receptor interaction studies; dependable batch-to-batch consistency | Standard curve construction; spike recovery assessment; functional receptor signaling experimentation |
Betacellulin quantification serves research teams across endocrinology, regenerative medicine, oncology, and cell biology. The reagent portfolio presented here supports their measurement needs from routine specimen panels through custom assay construction and mechanistic experimentation.
Quantitative access to betacellulin transforms an intriguing growth factor from descriptive biology into measurable mechanism. The coordinated portfolio anchored by the Human BTC(Betacellulin) ELISA Kit, expanded through development-grade reagent sets, orthogonal sandwich formats, polyclonal antibody reagents, and recombinant calibrator material, furnishes laboratories with a complete measurement ecosystem spanning routine quantification, custom assay construction, and functional verification. Every reagent is manufactured under consistent quality controls and validated for dependable behavior across serum, plasma, and culture specimen matrices. Deployed together, these tools allow investigators to trace ligand abundance from pancreatic islets through circulating compartments to receptor activation landscapes, connecting metabolic regulation, tissue regeneration, and tumor progression within one analytical narrative. For research laboratories probing EGF family signaling, this betacellulin measurement suite provides the standardized, dependable foundation required to translate ligand biology into reproducible scientific evidence and translational insight.
| Cat. No. | Product Name | Size | Species Reactivity | Application | Detection Method | |
| DEIA089 | Human Betacellulin ELISA Development Kit | 96T | Human | Quantitative | sELISA | Inquiry |
| DEIA3233 | Human BTC(Betacellulin) ELISA Kit | 96T | Human | Quantitative | sELISA | Inquiry |
| DEIA1411 | Betacellulin Human ELISA Kit | 96T | Human | Quantitative | Sandwich ELISA | Inquiry |
| DEIA-BJ1007 | Human BTC(Betacellulin) ELISA Kit | 96T | Human | Quantitative | sELISA | Inquiry |
Loading ......